18:03:42 EDT Sat 18 May 2024
Enter Symbol
or Name
USA
CA



News for U:AMPH from 2023-05-18 to 2024-05-17 - 22 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-09 16:12U:AMPHNews ReleaseAmphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
2024-05-08 16:21U:AMPHNews ReleaseAmphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
2024-04-30 16:07U:AMPHNews ReleaseAmphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
2024-04-01 06:02U:AMPHNews ReleaseAmphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
2024-03-06 16:06U:AMPHNews ReleaseAmphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference
2024-02-28 16:23U:AMPHNews ReleaseAmphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
2024-02-20 16:02U:AMPHNews ReleaseAmphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024
2024-01-02 06:01U:AMPHNews ReleaseAmphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-11-20 16:21U:AMPHNews ReleaseAmphastar Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference
2023-11-09 16:06U:AMPHNews ReleaseAmphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
2023-11-08 16:17U:AMPHNews ReleaseAmphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023
2023-11-01 16:12U:AMPHNews ReleaseAmphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023
2023-09-13 13:02U:AMPHNews ReleaseAmphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes
2023-09-13 01:00U:AMPHNews ReleaseAmphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes
2023-09-11 17:46U:AMPHNews ReleaseAmphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes
2023-09-11 17:00U:AMPHNews ReleaseAmphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes
2023-09-11 16:46U:AMPHNews ReleaseAmphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes
2023-08-31 16:06U:AMPHNews ReleaseAmphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference
2023-08-08 16:07U:AMPHNews ReleaseAmphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023
2023-08-02 16:10U:AMPHNews ReleaseAmphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023
2023-06-30 16:06U:AMPHNews ReleaseAmphastar Pharmaceuticals Completes Acquisition of BAQSIMI from Lilly
2023-05-31 16:16U:AMPHNews ReleaseAmphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference